Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

How Is Bristol-Myers’ Stock Performance Compared to Other Pharma Stocks?

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) is one of the leading biopharmaceutical companies focused on developing treatments for diseases like cancer, inflammatory, immunologic, cardiovascular, and fibrotic diseases. With a market cap of $96.5 billion, Bristol-Myers’ operations span various countries in the Americas, Europe, and the Indo-Pacific.

Companies worth $10 billion or more are generally described as “large-cap stocks.” BMY fits this bill perfectly. Given the company’s extensive operations and dominance in the pharma space, its valuation above this mark is unsurprising.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.